Treatment of multifocal Bowen's disease in immunocompromised women with surgery and topical imiquimod.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 22270432.
- Also identified by DOI 10.1097/AOG.0b013e318236f1a0 and PMC identifier 3266510.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In human immunodeficiency virus (HIV)-infected women, Bowen's disease may be difficult to treat successfully with surgery alone. Imiquimod cream, effective in treating Bowen's disease in healthy women, may be a useful postsurgical treatment in immunocompromised women. Two HIV-infected women had both Bowen's disease and severe cervical dysplasia. In both cases, Bowen's disease, but not cervical dysplasia, recurred after surgical treatment. When treated with topical 5% imiquimod cream twice weekly for 4 months, 70-80% reduction in lesions were observed in both patients. Follow-up biopsies of remaining lesions were vulvar intraepithelial neoplasia 1. Imiquimod cream, in combination with surgical treatment, may be an appropriate strategy for treatment of Bowen's disease in HIV-infected and other immunocompromised women.
Medical subject headings
- Aminoquinolines
- Antineoplastic Agents
- Bowen's Disease
- Skin Neoplasms
- Vulvar Neoplasms